Concepedia

Lihua E. Budde

LE

Statistics

Publications

97

Citations

7.4K

H-Index

38

Active since

2010

Affiliations

City Of Hope National Medical Center(Current)

City of Hope

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

Washington University in St. Louis

Lihua E. Budde is an author at City Of Hope National Medical Center specializing in oncology, cancer immunotherapy, and immunotherapy.

ORCID

Publications per year

2010–2025

97

Publications

97

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Frederick L. Locke, Sattva S. Neelapu, Nancy L. Bartlett et al. · Molecular Therapy · 2017 · 619 citations · Full text

, , +17

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 560 citations · Full text

, , +17

CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results

Brian G. Till, Michael C. Jensen, Jinjuan Wang et al. · Blood · 2012 · 530 citations

, , +17

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2020 · 486 citations · Full text

, , +17

Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study

Lihua E. Budde, Laurie H. Sehn, Matthew J. Matasar et al. · The Lancet Oncology · 2022 · 436 citations · Full text

, , +16

1–5 of 97